Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
Virology ; 366(2): 394-404, 2007 Sep 30.
Article in English | MEDLINE | ID: mdl-17555786

ABSTRACT

The human polyomavirus, JCV, has a highly restricted tropism and primarily infects glial cells. The mechanisms restricting infection of cells by JCV are poorly understood. Previously we developed and described a glial cell line that was resistant to JCV infection with the aim of using these cells to identify factors that determine JCV tropism. Gene expression profiling of susceptible and resistant glial cells revealed a direct correlation between the expression of inflammatory cytokines and susceptibility to JCV infection. This correlation manifested at the level of viral gene transcription. Previous studies have suggested a link between an increase in cytokine gene expression in HIV patients and the development of PML and these data supports this hypothesis.


Subject(s)
Cytokines/biosynthesis , JC Virus/growth & development , JC Virus/immunology , Neuroglia/virology , Oligonucleotide Array Sequence Analysis , Cell Line , Cytokines/genetics , Gene Expression Regulation, Viral , Genes, Reporter , Humans , Leukoencephalopathy, Progressive Multifocal/immunology , Leukoencephalopathy, Progressive Multifocal/virology , Luciferases/analysis , Luciferases/genetics , Viral Proteins/biosynthesis
2.
J Virol ; 80(24): 12079-85, 2006 Dec.
Article in English | MEDLINE | ID: mdl-17035332

ABSTRACT

The human polyomavirus JC virus (JCV) infects 70% of the population worldwide. In immunosuppressed patients, JCV infection can lead to progressive multifocal leukoencephalopathy (PML), a fatal demyelinating disease of the central nervous system (CNS). The majority of PML cases occur in the setting of human immunodeficiency virus (HIV) infection, and it has been suggested that the link between HIV and the development of PML is in part related to the production of numerous cytokines in the CNS during HIV infection. To examine the link between the expression of inflammatory cytokines and JCV infection, we tested an anti-inflammatory compound, cyclosporine A (CsA), for its ability to block JCV infection of glial cells. We found that CsA inhibited JCV infection by preventing the activation of the transcription factor nuclear factor of activated T cells 4 (NFAT4). Luciferase reporter assays and chromatin immunoprecipitation assays revealed that NFAT4 directly bound the JCV promoter during infection and was important for the activation of both early and late transcription. In addition, the expression of the JCV early viral gene products increased NFAT activity to further aid viral transcription. The necessity of NFAT for JCV infection suggests that calcium signaling and the activation of NFAT in glial cells are required for JCV infection of the CNS.


Subject(s)
Cyclosporine/pharmacology , JC Virus/metabolism , NFATC Transcription Factors/metabolism , Neuroglia/virology , Polyomavirus Infections/metabolism , Tumor Virus Infections/metabolism , Amino Acid Sequence , Blotting, Western , Cell Line , Chromatin Immunoprecipitation , DNA Primers , Humans , JC Virus/genetics , Luciferases , Molecular Sequence Data , Mutagenesis , NFATC Transcription Factors/antagonists & inhibitors , NFATC Transcription Factors/genetics , Promoter Regions, Genetic/genetics
3.
Nutr Metab (Lond) ; 3: 37, 2006 Sep 08.
Article in English | MEDLINE | ID: mdl-16961918

ABSTRACT

BACKGROUND: We have reported arginine-sensitive regulation of LAT1 amino acid transporter (SLC 7A5) in normal rodent hepatic cells with loss of arginine sensitivity and high level constitutive expression in tumor cells. We hypothesized that liver cell gene expression is highly sensitive to alterations in the amino acid microenvironment and that tumor cells may differ substantially in gene sets sensitive to amino acid availability. To assess the potential number and classes of hepatic genes sensitive to arginine availability at the RNA level and compare these between normal and tumor cells, we used an Affymetrix microarray approach, a paired in vitro model of normal rat hepatic cells and a tumorigenic derivative with triplicate independent replicates. Cells were exposed to arginine-deficient or control conditions for 18 hours in medium formulated to maintain differentiated function. RESULTS: Initial two-way analysis with a p-value of 0.05 identified 1419 genes in normal cells versus 2175 in tumor cells whose expression was altered in arginine-deficient conditions relative to controls, representing 9-14% of the rat genome. More stringent bioinformatic analysis with 9-way comparisons and a minimum of 2-fold variation narrowed this set to 56 arginine-responsive genes in normal liver cells and 162 in tumor cells. Approximately half the arginine-responsive genes in normal cells overlap with those in tumor cells. Of these, the majority was increased in expression and included multiple growth, survival, and stress-related genes. GADD45, TA1/LAT1, and caspases 11 and 12 were among this group. Previously known amino acid regulated genes were among the pool in both cell types. Available cDNA probes allowed independent validation of microarray data for multiple genes. Among genes downregulated under arginine-deficient conditions were multiple genes involved in cholesterol and fatty acid metabolism. Expression of low-density lipoprotein receptor was decreased in both normal and tumor cells. CONCLUSION: Arginine-sensitive regulation appears to be an important homeostatic mechanism to coordinate cell response and nutrient availability in hepatic cells. Genes predicted as arginine-responsive in stringent microarray data analysis were confirmed by Northern blot and RT-PCR. Although the profile of arginine-responsive genes is altered and increased, a considerable portion of the "arginome" is maintained upon neoplastic transformation.

4.
Aging Cell ; 3(4): 235-43, 2004 Aug.
Article in English | MEDLINE | ID: mdl-15268757

ABSTRACT

Hutchinson-Gilford progeria syndrome (HGPS) is a rare genetic disease with widespread phenotypic features resembling premature aging. HGPS was recently shown to be caused by dominant mutations in the LMNA gene, resulting in the in-frame deletion of 50 amino acids near the carboxyl terminus of the encoded lamin A protein. Children with this disease typically succumb to myocardial infarction or stroke caused by severe atherosclerosis at an average age of 13 years. To elucidate further the molecular pathogenesis of this disease, we compared the gene expression patterns of three HGPS fibroblast cell strains heterozygous for the LMNA mutation with three normal, age-matched cell strains. We defined a set of 361 genes (1.1% of the approximately 33,000 genes analysed) that showed at least a 2-fold, statistically significant change. The most prominent categories encode transcription factors and extracellular matrix proteins, many of which are known to function in the tissues severely affected in HGPS. The most affected gene, MEOX2/GAX, is a homeobox transcription factor implicated as a negative regulator of mesodermal tissue proliferation. Thus, at the gene expression level, HGPS shows the hallmarks of a developmental disorder affecting mesodermal and mesenchymal cell lineages. The identification of a large number of genes implicated in atherosclerosis is especially valuable, because it provides clues to pathological processes that can now be investigated in HGPS patients or animal models.


Subject(s)
Arteriosclerosis/genetics , Gene Expression Profiling , Gene Expression Regulation/genetics , Mesoderm/metabolism , Progeria/genetics , Adolescent , Arteriosclerosis/complications , Cell Line , Child , Down-Regulation/genetics , Extracellular Matrix/genetics , Female , Fibroblasts/metabolism , Genetic Predisposition to Disease/genetics , Heterozygote , Homeodomain Proteins/genetics , Humans , Lamin Type A/genetics , Male , Mutation , Progeria/complications , Progeria/pathology , RNA/genetics , RNA/isolation & purification , RNA/metabolism , Reverse Transcriptase Polymerase Chain Reaction , Transcription Factors/genetics , Up-Regulation/genetics
5.
J Biol Chem ; 278(14): 12563-73, 2003 Apr 04.
Article in English | MEDLINE | ID: mdl-12529326

ABSTRACT

The myc proto-oncogenes encode transcriptional regulators whose inappropriate expression is correlated with a wide array of human malignancies. Up-regulation of Myc enforces growth, antagonizes cell cycle withdrawal and differentiation, and in some situations promotes apoptosis. How these phenotypes are elicited is not well understood, largely because we lack a clear picture of the biologically relevant downstream effectors. We created a new biological system for the optimal profiling of Myc target genes based on a set of isogenic c-myc knockout and conditional cell lines. The ability to modulate Myc activity from essentially null to supraphysiological resulted in a significantly increased and reproducible yield of targets and revealed a large subset of genes that respond optimally to Myc in its physiological range of expression. The total extent of transcriptional changes that can be triggered by Myc is remarkable and involves thousands of genes. Although the majority of these effects are not direct, many of the indirect targets are likely to have important roles in mediating the elicited cellular phenotypes. Myc-activated functions are indicative of a physiological state geared toward the rapid utilization of carbon sources, the biosynthesis of precursors for macromolecular synthesis, and the accumulation of cellular mass. In contrast, the majority of Myc-repressed genes are involved in the interaction and communication of cells with their external environment, and several are known to possess antiproliferative or antimetastatic properties.


Subject(s)
Gene Expression Profiling , Proto-Oncogene Proteins c-myc/genetics , Animals , Cell Line , Cycloheximide/pharmacology , Genetic Complementation Test , Humans , Kinetics , Protein Synthesis Inhibitors/pharmacology , Rats , Receptors, Estrogen/genetics , Recombinant Fusion Proteins/genetics , Transgenes/physiology
SELECTION OF CITATIONS
SEARCH DETAIL
...